Misoprostol Prior to Intrauterine Contraceptive Device Insertion
Launched by ASSIUT UNIVERSITY · Apr 7, 2015
Trial Information
Current as of July 24, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 1. Include those who delivered by CS .
- • 2. Who accept to participate in the study.
- • 3. Desire IUD placement.
- • 4. Negative pregnancy test.
- • 5. No history or current history of pelvic inflammatory disease.
- • 6. No current cervicitis.
- • 7. No contraindication to IUD insertion (less than 4 week post partum,gynecological malignancy,unexplained vaginal bleeding and pregnancy).
- Exclusion Criteria:
- • 1. Any contraindication to IUD .
- • 2. Current pregnancy.
- • 3. Uterine anomaly.
- • 4. Undiagnosed abnormal uterine bleeding.
- • 5. Allergy to misoprostol.
- • 6. Patients contraindicated to administration of misoprostol.
- • 7. Women who delivered vaginally.
About Assiut University
Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials